Novavax (NVAX) Accounts Payables (2010 - 2026)
Novavax's Accounts Payables came in at $22.94 million for Q2 2026, down 54.7% from $50.6 million a year earlier but up 42.5% from the prior quarter.
Analysis
Novavax (NVAX) Accounts Payables (2010 - 2026) Analysis & Trends
At the end of FY2025, Novavax's Accounts Payables was $24.58 million, down 40.9% from FY2024.
- Accounts Payables has declined in each of the last three years, with a five-year compound annual growth rate of -14.7% (FY2020 to FY2025).
- Going back by year, Accounts Payables was $41.58 million in FY2024 (-68.6%), $132.61 million in FY2023 (-38.8%), $216.52 million in FY2022 (+70.4%) and $127.05 million in FY2021 (+133.8%).
- The five-year range for quarterly Accounts Payables is $15.23 million (Q3 2025) to $386.49 million (Q2 2022).
- Year-over-year, Accounts Payables has declined for 14 consecutive quarters, with an average decline of 51.5% over the last eight quarters.
- The fastest year-over-year change in Accounts Payables over five years came in Q2 2022 (growth of 422.3%), and the weakest in Q2 2023 (a decline of 77.4%).
- Business Quant data shows NVAX's Accounts Payables at $16.1 million (Q1 2026), $24.58 million (Q4 2025) and $15.23 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,261.99 Bn | 1,235.61 Bn | 20.46 Bn | 5.79 Bn |
| 2 | Johnson & Johnson | 678.93 Bn | 598.79 Bn | 17.30 Bn | 9.32 Bn |
| 3 | AbbVie | 518.29 Bn | 486.30 Bn | 13.12 Bn | 34.43 Bn |
| 4 | Merck | 365.98 Bn | 328.92 Bn | 13.19 Bn | 5.03 Bn |
| 5 | Novartis Ag | 316.85 Bn | 290.09 Bn | - | - |
| 6 | Astrazeneca | 293.40 Bn | 267.29 Bn | 13.26 Bn | -23.57 Bn |
| 7 | Amgen | 251.78 Bn | 203.43 Bn | 7.58 Bn | 2.95 Bn |
| 8 | Gilead Sciences | 210.61 Bn | 185.71 Bn | 6.73 Bn | 934.00 Mn |
| 9 | Pfizer | 166.87 Bn | 114.23 Bn | 12.56 Bn | 4.07 Bn |
| 10 | Novavax | 1.80 Bn | -1.06 Bn | 44.81 Mn | 24.94 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 24.94 Mn |
| Jun 30, 2026 | 22.94 Mn |
| Mar 31, 2026 | 16.10 Mn |
| Dec 31, 2025 | 24.58 Mn |
| Sep 30, 2025 | 15.23 Mn |
| Jun 30, 2025 | 50.60 Mn |
| Mar 31, 2025 | 34.16 Mn |
| Dec 31, 2024 | 41.58 Mn |
| Sep 30, 2024 | 57.52 Mn |
| Jun 30, 2024 | 79.96 Mn |
| Mar 31, 2024 | 57.72 Mn |
| Dec 31, 2023 | 132.61 Mn |
| Sep 30, 2023 | 101.91 Mn |
| Jun 30, 2023 | 87.25 Mn |
| Mar 31, 2023 | 124.80 Mn |
| Dec 31, 2022 | 216.52 Mn |
| Sep 30, 2022 | 145.00 Mn |
| Jun 30, 2022 | 386.49 Mn |
| Mar 31, 2022 | 135.13 Mn |
| Dec 31, 2021 | 127.05 Mn |
API Access
Novavax Accounts Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accounts-payables&ticker=NVAX&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accounts-payables", "ticker": "NVAX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=accounts-payables&ticker=NVAX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();